Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cyclic diadenosine monophosphate (c-di-AMP) is a naturally occurring bacterial second messenger and cyclic dinucleotide that plays a critical role in prokaryotic physiology, including cell wall homeostasis, potassium transport, osmotic stress response, and DNA integrity. In mammalian hosts, c-di-AMP acts as a potent pathogen-associated molecular pattern (PAMP) that directly binds to and activates the Stimulator of Interferon Genes (STING) pathway, triggering a type I interferon response and activating innate immunity. Due to its ability to stimulate robust humoral and cellular immune responses, c-di-AMP is widely utilized as a research tool and is being investigated as a mucosal vaccine adjuvant and immunotherapeutic agent.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cyclic diadenosine monophosphate.